Potential use of procalcitonin as biomarker for bacterial sepsis inpatients with or without acute kidney injury

Journal of Infection and Chemotherapy

Volumn 21, Issue 4, 2015, Pages 257-263

  Nakamura, Yoshihiko ^a   Murai, Akira ^a   Mizunuma, Mariko ^a   Ohta, Daiki ^a   Kawano, Yasumasa ^a   Matsumoto, Norihiko ^a   Nishida, Takeshi ^a   Ishikura, Hiroyasu ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Acute kidney injury; Diagnosis; Procalcitonin; Sepsis

Indexed keywords

PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ACUTE KIDNEY FAILURE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RIFLE CRITERIA; SEPSIS; ACUTE KIDNEY INJURY; BLOOD; COMPLICATION; MIDDLE AGED;

ACUTE KIDNEY INJURY; AGED; BIOMARKERS; CALCITONIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; SEPSIS;

EID: 84930374382     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.12.001     Document Type: Article

References (26)

1. Garnacho-Montero J., Garcia-Garmendia J.L., Barrero-Almodovar A., Jimenez-Jimenez F.J., Perez-Paredes C., Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003, 31:2742-2751.
2. Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002, 28:108-121.
3. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2012, 2013(41):580-637.
4. Chastre J., Wolff M., Fagon J.Y., Chevret S., Thomas F., Wermert D., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAm Med Assoc 2003, 290:2588-2598.
5. Singh N., Rogers P., Atwood C.W., Wagener M.M., Yu V.L. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000, 162:505-511.
6. Yu V.L., Singh N. Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia. Intensive Care Med 2004, 30:735-738.
7. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
8. Rangel-Frausto M.S., Pittet D., Costigan M., Hwang T., Davis C.S., Wenzel R.P. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAm Med Assoc 1995, 273:117-123.
9. Pierrakos C., Vincent J.L. Sepsis biomarkers: a review. Crit Care 2010, 14:R15.
10. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341:515-518.
11. Cho S.Y., Choi J.H. Biomarkers of sepsis. Infect Chemother 2014, 46:1-12.
12. Herzum I., Renz H. Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem 2008, 15:581-587.
13. Christ-Crain M., Muller B. Procalcitonin in bacterial infections - hype, hope, more or less?. Swiss Med Wkly 2005, 135:451-460.
14. Amour J., Birenbaum A., Langeron O., Le Manach Y., Bertrand M., Coriat P., et al. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 2008, 36:1147-1154.
15. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute Dialysis Quality Initiative w. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212.
16. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992.
17. Murugan R., Kellum J.A. Acute kidney injury: what's the prognosis?. Nat Rev Nephrol 2011, 7:209-217.
18. Mehanic S., Baljic R. The importance of serum procalcitonin in diagnosis and treatment of serious bacterial infections and sepsis. Mater Sociomed 2013, 25:277-281.
19. Meisner M., Lohs T., Huettemann E., Schmidt J., Hueller M., Reinhart K. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 2001, 18:79-87.
20. Ricci Z., Ronco C., D'Amico G., De Felice R., Rossi S., Bolgan I., et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant 2006, 21:690-696.
21. Uchino S., Bellomo R., Goldsmith D., Bates S., Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006, 34:1913-1917.
22. Monti G., Herrera M., Kindgen-Milles D., Marinho A., Cruz D., Mariano F., et al. The DOse REsponse multicentre international Collaborative Initiative (DO-RE-MI). Contrib Nephrol 2007, 156:434-443.
23. Opatrna S., Klaboch J., Opatrny K., Holubec L., Tomsu M., Sefrna F., et al. Procalcitonin levels in peritoneal dialysis patients. Perit Dial Int 2005, 25:470-472.
24. Steinbach G., Bolke E., Grunert A., Storck M., Orth K. Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 2004, 116:849-853.
25. Herget-Rosenthal S., Marggraf G., Pietruck F., Husing J., Strupat M., Philipp T., et al. Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 2001, 16:975-979.
26. Shirakawa K., Naitou K., Hirose J., Takahashi T., Furusako S. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med 2011, 49:937-939.